Login / Signup

Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting.

Jean-Baptiste AssiéChristos ChouaidHilario NunesDorothée ReynaudAnne-Françoise GaudinValentine GrumbergRonan JolivelBaptiste JouanetonFrançois-Emery CottéBoris Duchemann
Published in: Therapeutic advances in medical oncology (2023)
In this large cohort of aNSCLC patients with ILD, outcomes are similar to those obtained in the non-ILD population. Immunotherapy could be beneficial for these patients.
Keyphrases